Showing results (121-130 of 1,008) with videos related to

Sort By:
Pageof 101
Journal of Human Hypertension|February 21, 2024
The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke StudyLiping Huang, Qiang Li, Jason Hy Wu, et al.
Diabetes Care|August 9, 2015
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetesMerlin C Thomas, Mark Woodward, Bruce Neal, et al.
BMC Public Health|May 13, 2016
Effects of a community-based salt reduction program in a regional Australian populationMary-Anne Land, Jason H Y Wu, Adriana Selwyn, et al.
BMC Public Health|November 17, 2018
Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural IndiaDevarsetty Praveen, David Peiris, Stephen MacMahon, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Contemporary model for cardiovascular risk prediction in people with type 2 diabetesAndre Pascal Kengne, Anushka Patel, Michel Marre, et al.
The Lancet. Rheumatology|January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS ProgramJingWei Li, Sunil V Badve, Zien Zhou, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2012
The risk of cancer in people with diabetes and chronic kidney diseaseGermaine Wong, Sophia Zoungas, Serigne Lo, et al.
Heart, Lung & Circulation|August 29, 2020
Sodium Reduction: How Big Might the Risks and Benefits Be?Xuejun Yin, Maoyi Tian, Bruce Neal
Diabetes & Vascular Disease Research|March 3, 2012
Effects of SGLT2 inhibitors on cardiovascular outcomesCeline Foote, Vlado Perkovic, Bruce Neal
Pageof 101